Controlling your LDL or bad cholesterol level may help in minimize your risk of dementia and Alzheimer's disease , a study ...

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.

Monday is lipoprotein(a) awareness day. ABC News chief medical correspondent Dr. Tara Narula shares what you need to know.

People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia, including ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

A dose of an experimental drug reduced the levels of a fatal type of cholesterol for up to a year despite previous knowledge that it's untreatable. NBC News reported that pharmaceutical company Eli ...

LDL levels below 70 mg/dL are tied to a lower risk of developing dementia in general and Alzheimer’s disease-related dementia ...

Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) ...

AZD0780 demonstrated a statistically significant low-density lipoprotein cholesterol reduction when administered on top of ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...